Introduction 62
Cervical cancer is a global public health problem caused by persistent HPV infection 63 leading to malignancy 1 . For women, it ranks second in terms of cancer incidence and 64 mortality worldwide, and first in several developing countries. The global burden estimates 65 suggest that annual incidence is 510 000 and mortality is 288 000 each year worldwide. 66
In France, cervical cancer is ranked number 8 in terms of cancer incidence. 2 In the French 67 overseas territories in the Americas the incidence rates are situated between what is observed 68 in mainland France and the Caribbean 3 , one of the most affected regions worldwide 4 . In 69
French Guiana, cervical cancer is the second most frequent cancer in females 5 still causing 70 significant mortality 6 . In 2002-2005, the standardized incidence of cervical cancer was 30.3 71 per 100 000 women, which was close to that of neighboring Brazil 7 . French Guiana is a 72 sparsely populated region covered by primary forest, with populations living in remote parts 73 of the territory only accessible by boat. Despite a network of health centers connected to the 74 main hospital, there are some difficulties to access care. It was recently shown that despite the 75 absence of significant difference in incidence between rural areas and urban areas, there were 76 some differences in the diagnostic delays with 77% of the women from the rural areas with 77 lesions metastasizing beyond the cervix versus 44% for women living in urban areas 5 . Health 78 professionals concur that given the early start of sex life in populations living in these remote 79 parts 8 , the risk of cervical lesions due to HPV should be high. In these remote areas, sexual 80 transmission is also seen for the HIV epidemic, which has soared from zero to over 1% within 81 a decade 9 . Given that HPV 16-18 are involved in 73% of cervical cancers in Europe, 82 vaccination against these genotypes is now recommended in France. However, little is known 83 about the epidemiology of HPV in French Guiana, a French territory with very different 84 centers' workers were also informed. Local radio messages informed the population of the 107 dates of the study team's presence in the village. During the inclusion, women wishing to be 108 screened came to the health center where the project was explained to them, and where the 109 6/13 questionnaire was filled and samples were taken and transferred in a cooler until the end of 110 the mission. The samples were then send to the Virology laboratory of Fort de France 111
Hospital, in Martinique where extraction and genotyping were performed using an automated 112 method in order to reduce the risk of error and contamination. DNA extraction was performed 113 using a minimum of 2 ml of sample in liquid phase. 114 HPV infection was defined by the detection of HPV DNA using the GREINER-BIO-ONE kit, 115 used at the Virology laboratory in Fort de France University Hospital. This kit allows the 116 identification of High risk HPV genotypes : 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 117 66, 68, 70, 73, 82 and of low risk HPV genotypes: 6, 11, 40, 42, 43, 44, 55 . This kit allowed 118 the identification of multiple infections. Cytologic anomalies were described using the 2001 Maripasoula, 32 in Taluen, and 37 in Antecume Pata. On the Oyapock 98 were included in 160 Saint Georges, 60 in Camopi, and 79 in Trois Sauts. The ratio between the number of women 161 included in each village and the estimated target population number in each village ranged 162 between a minimum of 6% in Grand Santi to 41.7% in Camopi. Overall, 9.3% of women from 163 the target population entered the study. Overall, sexual relations started at a young age with 164 27% percent of the surveyed women had their first sexual relation before age 15, and 50% 165 before age 16. 166 Table one shows very high HPV prevalence notably for high risk viruses.The overall age-167 standardized prevalence rate was 35%. Figure 1 shows there was a U shaped evolution of 168 overall HPV prevalence by age and high risk HPV prevalence by age, with women over 50 169 years at highest risk for HPV, followed by the 20 to 29 years group. Maroon language was 170 associated with a greater HPV prevalence whereas Portuguese language was associated with a 171 lower prevalence. Other risk factors such as number of sex partners, parity, age at first sex, 172 education, contraception, or smoking were not significantly linked to differences in HPV 173 prevalence. None of the women had declared receiving the HPV vaccine. 174 175 Figure 2 shows the geographical differences in HPV prevalence with the lower part of the 176 Maroni river having the highest prevalence. Table 3 and table 4 The HPV prevalence varied according to age, and was highest in the Maroon villages. As 204 observed elsewhere, and notably in Latin America and Africa, there was a U-shaped curve of 205 HPV prevalence by age group 11, 12 . The prevalence rate reflects the combination of incidence, 206 new infections, and the duration of infection. The U shape may have reflected new infections 207 in these age groups and/or a slower clearance of viruses in older parous women 13 .As other 208 studies elsewhere, apart from age few variables were able to predict the risk of having a 209 positive HPV test 13, 14 . 210
The study limitations were that inclusion was voluntary, and that women living far from the 211 health centers may have been less likely to be included in the study. studies showing a high incidence of cervical cancer suggest that HPV testing would be a 219 better method than the default method which did not detect over 27% of women with HPV 220 infection. HPV testing can also be performed using self tests, which could make it more 221 acceptable for some women 15 and less human resources-intensive. Given the high prevalence 222 of HPV infection and the high incidence of cervical cancer in French Guiana, emphasis on 223 vaccination and expanded and innovative screening seems important 16, 17 . The exact HPV 224 vaccine coverage in these remote territories is unknown, but it is presumably very low. None 225 of the surveyed women reported having been vaccinated. Given the early age of sexual life 226 initiation, the optimal age of vaccination may need to be shifted downwards when compared 227 to recommendations in mainland France. When looking at the variety of HPV genotypes 228 present in these remote territories of French Guiana, the nonavalent HPV vaccines would 229 seem more appropriate that the bivalent or tetravalent vaccines, which do not cover other 230 circulating high risk genotypes 18 . This nonavalent vaccine has been recommended in France   19   231 and it would presumably have an even greater added value in French Guiana. Presently, given 232 the large proportion of the population that do not have health insurance in these remote areas, 233 the cost of the vaccine is prohibitive. Given the present results, Health authorities should 234 tackle these economic obstacles to ensure that populations have access to this vaccine. 235
236
Overall, the present results show that over a third of women were infected with HPV, and that 237 over a quarter of women with high risk HPV infection had normal cytology. Given the high 238 incidence of cervical cancer in French Guiana and the relative delay in diagnosis 6, 20 , these 239 results emphasize the importance of vaccination, preferably with a nonavalent vaccine. 240
However, in this region where a large portion of the population has no health insurance, this 241 still represents a challenge. Finally, the results underscore the importance of expanded 242 screening using HPV tests given their better sensitivity than cytology, and their potential for 243 
